2017-11-14T12:47:53-06:00 2016-12-31 382656556 GORDON ADVISORS PC 1301 W Long Lake Road Ste 200 Troy MI 48098 990 2016-01-01 800613664 Team Joseph Inc TEAM 2483300430 3050 UNION LAKE ROAD No 8F COMMERCE TOWNSHIP MI 48382 Marissa Penrod President & CEO 2483300430 2017-11-14 1 Kevin E Klein CPA P00539501 2489520200 12.199.18.242 2017-11-14 08:49:23 ES P DA39A3EE5E6B4B0D3255BFEF95601890AFD80709 B5661B19799D706419765669CF1BFF7266BB1DE1 2016 2017-02-10 21:41:12Z MARISSA PENROD 3050 UNION LAKE ROAD No 8F COMMERCE TOWNSHIP MI 48382 543694 0 X teamjoseph.info X 2010 MI TO FUND CUTTING EDGE RESEARCH IN ORDER TO FIND A CURE OR TREATMENT FOR DUCHENNE MUSCULAR DYSTROPHY. ADDITIONALLY, TEAM JOSEPH WILL ASSIST FAMILIES WITH MEDICAL EXPENSES DIRECTLY RELATED TO THE CARE OF A CHILD DIAGNOSED WITH DUCHENNE MUSCULAR DYSTROPHY. 4 2 3 30 0 0 206131 470483 134612 42500 0 0 13268 -15872 354011 497111 320927 0 0 0 80797 84018 0 0 97080 163081 158254 564805 242272 -210794 254839 637356 892195 0 0 637356 892195 X TO FUND CUTTING EDGE RESEARCH IN ORDER TO FIND A CURE OR TREATMENT FOR DUCHENNE MUSCULAR DYSTROPHY. ADDITIONALLY, TEAM JOSEPH WILL ASSIST FAMILIES WITH EXPENSES DIRECTLY RELATED TO THE CARE OF A CHILD DIAGNOSED WITH DUCHENNE MUSCULAR DYSTROPHY. 1 0 118875 42500 TO FUND CUTTING EDGE RESEARCH IN ORDER TO FIND A CURE OR TREATMENT FOR DUCHENNE MUSCULAR DYSTROPHY. ADDITIONALY, TEAM JOSEPH WILL ASSIST FAMILIES WITH EXPENSES DIRECTLY RELATED TO THE CARE OF A CHILD DIAGNOSED WITH DUCHENNE MUSCULAR DYSTROPHY. 118875 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 1 3 1 0 0 0 0 0 0 0 0 X 4 2 0 0 0 0 0 0 0 1 1 0 0 1 1 0 0 1 1 1 1 0 MI X MARISSA PENROD 2483300430 3050 UNION LAKE ROAD 8F COMMERCE TWP MI 48382 MARISSA PENROD PRESIDENT & CEO 40.00 X X 50000 0 0 LYNDA SNAGE VICE PRESIDENT 2.00 X X 0 0 0 DORENE PULGINI DIRECTOR 10.00 X 7680 0 0 DINA KENKEL DIRECTOR 2.00 X 0 0 0 57680 0 0 0 0 0 0 0 108611 361872 470483 RESEARCH PROJECT COLLA 900099 42500 42500 42500 30711 108611 46583 -15872 -15872 497111 42500 0 -15872 X 57680 38840 3268 15572 20000 6000 6000 8000 6338 3423 887 2028 2937 2937 40708 39000 1708 33999 18359 4760 10880 13501 3729 3788 5984 870 870 11270 6086 1578 3606 3073 2908 165 346 74 272 447 447 Fundraising 50573 50573 TJ Appreciation Dinner 530 530 242272 118875 26317 97080 635471 805422 84500 3269 996 1885 2273 637356 892195 0 0 X 637356 892195 637356 892195 637356 892195 254839 0 X 0 0 0 X 192211 229617 1236312 206131 454049 2318320 134612 42500 177112 192211 229617 1236312 340743 496549 2495432 85000 87000 77000 65000 117727 431727 32000 51733 14506 13251 63210 174700 117000 138733 91506 78251 180937 606427 1889005 192211 229617 1236312 340743 496549 2495432 0.75700 0.83300 0.00000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 3269 996 2273 2273 Golf Outing 47145 27315 19830 16363 3560 J4J 92177 81296 10881 8111 12006 6543 139322 108611 30711 8111 16363 12006 10103 46583 -15872 Form 990, Part III, line 2 THE ORGANIZATION DEDICATED NEW PROGAMMATIC EFFORTS AND FINANCIAL RESOURCES TO ADDRESSING REGULATORY PROCESS HURDLES SLOWING RESEARCH. NAVIGATING THE REGULATORY PROCESS IS A CRITICAL PART OF LATER-STAGE RESEARCH. AS TREATMENTS SUCCESSFULLY ADVANCE THROUGH THE DRUG DEVELOPMENT PIPELINE (THANKS IN PART TO TEAM JOSEPH'S WORK) THEY ARE NOW REACHING THIS STAGE. IN 2016, ONE DRUG WAS A STAGE AT WHICH THE SUCCESS OF ITS CONTINUED DEVELOPMENT DEPENDED SUBSTANTIALLY ON FDA GUIDANCE. ACCORDINGLY, TEAM JOSEPH UNDERTOOK RESEARCH ADVOCACY EFFORTS FOCUSED ON ENSURING THE FDA AND OTHER STAKEHOLDERS IN THE DRUG DEVELOPMENT PROCESS (E.G., DRUG DEVELOPMENT COMPANIES) WORK AS EFFICIENTLY AND EFFECTIVELY AS POSSIBLE TO DEVELOP AND REVIEW NEW DRUGS. PART OF THIS INCLUDED HIRING A FIRM THAT HELPED THE ORGANIZATION SHAPE AND DEPLOY MESSAGING TO ENGAGE THE COMMUNITY, CONGRESS, AND THE FDA. Form 990, Part VI, Section B, line 11b The return is submitted to the governing body for their approval. Form 990, Part VI, Section B, line 15 Compensation of other employees is reasonable. Form 990, Part VI, Section C, line 19 Governing documents disclosure explanation available upon request. Form 990, Part IX, line 11g Professional Development : Program service expenses 0. Management and general expenses 843. Fundraising expenses 0. Total expenses 843. Payroll Service Fee: Program service expenses 0. Management and general expenses 865. Fundraising expenses 0. Total expenses 865. CONSULTING - TREATMENT APPROVAL: Program service expenses 39,000. Management and general expenses 0. Fundraising expenses 0. Total expenses 39,000.